Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00531869
Other study ID # CPHS Protocol #2007-7-27
Secondary ID
Status Recruiting
Phase Phase 0
First received September 18, 2007
Last updated July 31, 2008
Start date May 2008
Est. completion date October 2010

Study information

Verified date July 2008
Source University of California, Berkeley
Contact Jill Luoto, Phd Candidate Economics
Phone (510) 643-5414
Email luoto@are.berkeley.edu
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Consumer preferences for POU technologies vary across consumers and products, and largely determine their adoption and subsequent usage. This is a marketing study that asks which products consumers prefer and why, and what is their willingness to pay, as understanding this is crucial to attain their widespread adoption and usage.


Description:

Visit 400 households and distribute 1 of 3 different POU technologies on randomized basis for a two-month trial. Cycle each household through trials with all 3 technologies in random order such that at the end of 6 months all households have experienced 2-month trials with each technology.


Recruitment information / eligibility

Status Recruiting
Enrollment 0
Est. completion date October 2010
Est. primary completion date May 2010
Accepts healthy volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- At least partial reliance on turbid water supply

Exclusion Criteria:

- At least partial reliance on turbid water supply

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms

  • Consumer Preferences and Use of POU Products
  • Consumer Willingness to Pay for POU Products

Intervention

Behavioral:
biases towards products


Locations

Country Name City State
Kenya Care Kenya Kisumu

Sponsors (2)

Lead Sponsor Collaborator
University of California, Berkeley Procter and Gamble

Country where clinical trial is conducted

Kenya, 

Outcome

Type Measure Description Time frame Safety issue
Primary Consumer preferences and use of POU products
Secondary Consumer willingness to pay for POU products